Sexual well being firm Wisp expanded its partnership with TBD Well being, the corporate shared with MedCity Information. On Wednesday, it started providing entry to TBD Well being's sexually transmitted infections/illnesses (STD/STD) testing kits on its website.

San Francisco-based Wisp is a digital well being care supplier for vaginal well being, reproductive well being and sexual well being. The direct-to-consumer platform affords contraception, in addition to remedies for urinary tract infections, genital herpes, bacterial vaginosis and yeast infections. Primarily based in New York Metropolis, TBD Well being is a web-based and in-person sexual well being care platform. It affords at-home STD testing and emergency contraception, in addition to telemedicine consultations. The in-person clinics are situated in Las Vegas and Denver.

In January, the businesses introduced that Wisp telehealth sufferers may very well be referred to TBD Well being's in-person clinics for STD testing, PrEP prescriptions, UTI remedies and different companies. On account of the expanded collaboration, Wisp members can now order TBD Well being's STD/STD take a look at kits without cost on the Wisp web site. They carry out the take a look at by offering a urine pattern and returning the equipment to one among TBD Well being's accomplice laboratories. If the take a look at is constructive, they may see a TBD physician to get remedy and perceive subsequent steps.

“We’re on an ongoing mission to offer sufferers with the remedies and care they want, after they want them, with out trouble, judgment and with out insurance coverage. … This partnership helps us additional democratize entry to sexual well being care and marks the primary time we’re experimenting with at-home diagnostics on our platform,” Wisp CEO Monica Cepak stated in an e-mail.

Wisp pays TBD Well being for its stock, Cepak added.

The corporate's announcement comes at a time when the variety of STD circumstances is growing. Greater than 2.5 million circumstances of syphilis, gonorrhea and chlamydia had been reported within the U.S. in 2022, in keeping with the Facilities for Illness Management and Prevention. Syphilis circumstances elevated by 80% within the US between 2018 and 2022.

“We acknowledge that there has by no means been a better want for STD/STI remedy and testing choices,” Cepak stated. “By this partnership, we’re assembly affected person demand whereas working to teach customers about what signs appear to be and what preventative and post-diagnosis choices are.”

The corporate additionally just lately added two new drugs to its website: M. Hominis Remedy and Ureaplasma Remedy. These micro organism don’t often trigger issues, however could cause ache, discharge, vaginal odor and fertility issues if an imbalance happens. The medication had been created to “successfully fight the imbalance of assorted micro organism and rapidly assist uncomfortable genital signs,” Cepak stated.

Different corporations providing sexual well being assist to customers embody Ro and Hims and Hers.